ConductScience.org, home

Paper6788166

Haemolytic anaemia after cisplatin treatment.

Levi JA and 2 others. Br Med J (Clin Res Ed), 1981. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. Haemolytic anaemia after cisplatin treatment. Papers, record 6788166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6788166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Haemolytic anaemia after cisplatin treatment.
PubMed
Journal
Br Med J (Clin Res Ed)
PubMed
Year
1981
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Levi JAJ A
2Aroney RSR S
3Dalley DND N

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, HemolyticMajor topic
CisplatinMajor topic
Adult
Drug Therapy, Combination
Humans
Lung Neoplasms
Male
Teratoma
Testicular Neoplasms

Source PubMed

Download CSV of topics

References5

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1380759Cis-platinum: a new anticancer agent.Br Med J1979https://conductscience.org/library/papers/380759PubMed
2498147Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.Cancer Treat Rep1979https://conductscience.org/library/papers/498147PubMed
3387223Toxic effects of cis-dichlorodiammineplatinum(II) in man.Cancer Treat Rep1979https://conductscience.org/library/papers/387223PubMed
47188625Cisplatin-induced hemolysis.N Engl J Med1980https://conductscience.org/library/papers/7188625PubMed
57192364Cisplatin toxicity for erythroid precursors.N Engl J Med1981https://conductscience.org/library/papers/7192364PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
31308689Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway.Onco Targets Ther2019https://conductscience.org/library/papers/31308689PubMed
29445233In vitro cytotoxicity activity of novel Schiff base ligand-lanthanide complexes.Sci Rep2018https://conductscience.org/library/papers/29445233PubMed
29147201Carboplatin Induced Fatal Autoimmune Hemolytic Anemia: First Reported Case.World J Oncol2010https://conductscience.org/library/papers/29147201PubMed
28750057Bactericidal activity of alpha-bromocinnamaldehyde against persisters in Escherichia coli.PLoS One2017https://conductscience.org/library/papers/28750057PubMed
26315556Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway.Int J Oncol2015https://conductscience.org/library/papers/26315556PubMed
26288702Nonpreventive Role of Aerobic Exercise Against Cisplatin-induced Nephrotoxicity in Female Rats.Int J Prev Med2015https://conductscience.org/library/papers/26288702PubMed
24523856Benzene-poly-carboxylic acid complex, a novel anti-cancer agent induces apoptosis in human breast cancer cells.PLoS One2014https://conductscience.org/library/papers/24523856PubMed
7828281Hypersensitivity and cross-reactivity to cisplatin and analogues.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7828281PubMed
7497593Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7497593PubMed
6889884Effects of cisplatin on different haemopoietic progenitor cells in mice.Br J Cancer1982https://conductscience.org/library/papers/6889884PubMed
3719897Adverse effect of cis-diamminedichloroplatinum II (CDDP) on porphyrin metabolism in man.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3719897PubMed
3342471Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3342471PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6788166

GET https://conductscience.org/api/papers/v1/6788166/authors